XML 39 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Discontinued Operations - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 28, 2023
May 11, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Consideration on acquisition transferred $ 8,000          
Research and Development Expense     $ 105 $ 339 $ 149 $ 911
Tisento Therapeutics Holdings Inc            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Equity securities, percentage 10.00%          
Tisento Therapeutics Holdings Inc | Discontinued Operations            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Consideration on acquisition transferred   $ 8,000        
Research and Development Expense   $ 2,400        
Equity securities, percentage   10.00%